107 related articles for article (PubMed ID: 11016973)
1. Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma.
Balicki D; Reisfeld RA; Pertl U; Beutler E; Lode HN
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11500-4. PubMed ID: 11016973
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy.
Pertl U; Luster AD; Varki NM; Homann D; Gaedicke G; Reisfeld RA; Lode HN
J Immunol; 2001 Jun; 166(11):6944-51. PubMed ID: 11359856
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12.
Lode HN; Xiang R; Duncan SR; Theofilopoulos AN; Gillies SD; Reisfeld RA
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8591-6. PubMed ID: 10411920
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma.
Lode HN; Dreier T; Xiang R; Varki NM; Kang AS; Reisfeld RA
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2475-80. PubMed ID: 9482910
[TBL] [Abstract][Full Text] [Related]
5. Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene.
Corrias MV; Basso S; Meazza R; Musiani P; Santi L; Bocca P; Occhino M; Ferrini S; Pistoia V
Cancer Gene Ther; 1998; 5(1):38-44. PubMed ID: 9476965
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
[TBL] [Abstract][Full Text] [Related]
8. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
[TBL] [Abstract][Full Text] [Related]
10. Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein.
Wang Y; Xu M; Che M; Von Hofe E; Abbas A; Kallinteris NL; Lu X; Liss ZJ; Forman JD; Hillman GG
Hum Gene Ther; 2005 Feb; 16(2):187-99. PubMed ID: 15761259
[TBL] [Abstract][Full Text] [Related]
11. Retroviral-mediated IL-2 gene transfer into murine neuroblastoma.
Cho HS; Song JY; Park CY; Lyu CJ; Kim BS; Kim KY
Yonsei Med J; 2000 Feb; 41(1):76-81. PubMed ID: 10731923
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12.
Davidoff AM; Kimbrough SA; Ng CY; Shochat SJ; Vanin EF
J Pediatr Surg; 1999 May; 34(5):902-6; discussion 906-7. PubMed ID: 10359203
[TBL] [Abstract][Full Text] [Related]
13. Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
Tanaka M; Saijo Y; Sato G; Suzuki T; Tazawa R; Satoh K; Nukiwa T
Cancer Gene Ther; 2000 Nov; 7(11):1481-90. PubMed ID: 11129290
[TBL] [Abstract][Full Text] [Related]
14. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.
Suzuki K; Nakazato H; Matsui H; Hasumi M; Shibata Y; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
J Leukoc Biol; 2001 Apr; 69(4):531-7. PubMed ID: 11310838
[TBL] [Abstract][Full Text] [Related]
15. Combination nonviral cytokine gene therapy for head and neck cancer.
Li D; Zeiders JW; Liu S; Guo M; Xu Y; Bishop JS; O'Malley BW
Laryngoscope; 2001 May; 111(5):815-20. PubMed ID: 11368072
[TBL] [Abstract][Full Text] [Related]
16. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
17. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
[TBL] [Abstract][Full Text] [Related]
18. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
19. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
Sandler AD; Chihara H; Kobayashi G; Zhu X; Miller MA; Scott DL; Krieg AM
Cancer Res; 2003 Jan; 63(2):394-9. PubMed ID: 12543793
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated gene transfer of B7-1 and MHC class II converts a poorly immunogenic neuroblastoma into a highly immunogenic one.
Heuer JG; Tucker-McClung C; Gonin R; Hock RA
Hum Gene Ther; 1996 Nov; 7(17):2059-68. PubMed ID: 8934220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]